PACBVSTXG• 12 Months (Normalized)
PACB vs TXG (Pacific Biosciences of California Inc. vs 10x Genomics Inc.)
Showing Closing Date Range from Oct 7, 2025 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
PACB Performance $2.72
+94.29%
Pacific Biosciences of California Inc.
Normalized Baseline0.00%
TXG Performance $76.1
+556.03%
10x Genomics Inc.
Normalized Baseline0.00%
Alpha Spread Margin TXG LEADS
-461.74 pts
TXG outperforming by 461.74 percentage points
PACBTXG
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
PACB TXG
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | PACB Price | PACB Gain (%) | TXG Price | TXG Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 07, 2026 | $2.72 | +94.29% | $76.10 | +556.03% | -461.74% |
| Oct 06, 2026 | $2.70 | +92.86% | $80.66 | +595.34% | -502.48% |
| Oct 05, 2026 | $2.87 | +105.00% | $97.74 | +742.59% | -637.59% |
| Oct 02, 2026 | $2.54 | +81.43% | $93.50 | +706.03% | -624.60% |
| Oct 01, 2026 | $2.51 | +79.29% | $88.76 | +665.17% | -585.88% |
| Sep 30, 2026 | $2.37 | +69.29% | $90.36 | +678.97% | -609.68% |
| Sep 29, 2026 | $1.83 | +30.71% | $90.04 | +676.21% | -645.50% |
| Sep 28, 2026 | $1.71 | +22.14% | $88.50 | +662.93% | -640.79% |
| Sep 25, 2026 | $- | $85.71 | +638.88% | - | |
| Sep 24, 2026 | $1.46 | +3.93% | $84.11 | +625.09% | -621.16% |
| Sep 23, 2026 | $1.41 | +0.71% | $75.62 | +551.90% | -551.19% |
| Sep 22, 2026 | $- | $80.70 | +595.69% | - | |
| Sep 21, 2026 | $1.36 | -2.86% | $79.10 | +581.90% | -584.76% |
| Sep 18, 2026 | $1.37 | -2.14% | $76.60 | +560.34% | -562.48% |
| Sep 17, 2026 | $1.38 | -1.43% | $76.97 | +563.53% | -564.96% |
Page 1 of 17